It is also regularly ranked as one of Fortune’s best 100 workplaces. #129 Gilead Sciences Revenue: US$27,3mn Growth: 4,961 percent Gilead has arguably had the best year out of all the pharmaceutical companies on the list, with an incredible increase in profits of nearly 5,000 pe...
Top pharma R&D 2023: Companies investing the most Outside of Merck & Co.’s eye-popping R&D figures in 2023, J&J is taking a more moderate approach, with a 3.3% increase in R&D expenses to $15.1 billion, while actively prioritizing assets ina few core areas, including oncology, neuroscience...
The top 20 pharma companies by 2021 revenue Eli Lilly delivered similar gains thanks largely to its diabetes and weight loss drugs Mounjaro and Zepbound, which combined for sales of more than $5.3 billion as the company's revenue increased 20% from $28.5 billion to $34.1 billion. Novo and ...
Fosun Pharma has been recognized by multiple authoritative institutions in innovative R&D, ESG and other areas. The Company ranked in the top four of China’s 2023 Top 100 Pharmaceutical Industry, was included in the “China Best Managed Companies” List (BMC) for the second consecutive year and...
released the rankings of 2022 Top 100 Chinese Pharmaceutical Innovative Companies and China's 50 Pharmaceutical Innovation and Upgrading Role Models. Hansoh Pharma was ranked in the first echelon of China's Top 100 Innovative Pharmaceutical Companies for the fourth consecutive year and among the top ...
dollars’ worth of net profit per employee, which ranked the company second among the global top 15 pharmaceutical companies. Net profit per employee data can be used as an indicator to gauge how profitable a company (or industry) is. Biogen Biogen is a biotechnology & pharmaceutical company,...
(S&P) 500 index, according to data from The Economist.20 Specialty and mid-tier biopharma are the fastest growing firms in the industry; of the 50 leading companies ranked by growth of total revenue from 2005 to 2006, only five are Big Pharma, with Roche, GSK, sanofi-aventis, Boeh...
Fosun Pharma is also included in the SSE Private Enterprise 50 Index and SSE Social Responsibility Index. According to IMS Health Incorporated ("IMS"), the Group was one of the top five domestic pharmaceutical companies in the PRC by revenue in the pharmaceutical manufacturing segment in 2011. ...
dollars more than the second ranked country. One reason for the disparity between countries is the price of prescription medications: in the United States, the prices of branded drugs increased significantly between 2011 and 2019. Many pharmaceutical manufacturers argue that prices need to be raised ...
(CPIA) show that companies mainly engaged in API production recorded operating revenue of Rmb394.460bn in 2020, up 3.70% YoY. The overall revenue of the chemical pharmaceutical segment accounted for 44.00% of the total pharmaceutical manufacturing revenue in 2020, making it one of the most ...